Innovative risk assessment for individualizing treatment in chronic lymphocytic leukemia
Funding Body: Εuropean Commission
Η2020, Marie Skłodowska-Curie Individual Fellowships (IF-EF) 2015 (MSCA-IF-2015-EF)
Chronic lymphocytic leukemia faces high-challenging and timely problems related to the classification and efficient prognosis of patients at the time of diagnosis and the attempt to personalize the treatment. CLLassify addresses these issues in a pioneering fashion within a multidisciplinary collaboration, proposing an improved classification of the patients, based on innovative statistical techniques as well as the novel aspect of personalized prediction of the need for treatment at a specific time point for the individual patient.